Efficacy and safety of sequential IV/PO moxifloxacin for the treatment of severe community-acquired pneumonia

類似資料

• Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study
  著者:: Schaper, N. C., 等
  出版事項: (2012)
• Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI)
  著者:: Kuzman, Ilija, 等
  出版事項: (2014)
• Moxifloxacin for Community-Acquired Pneumonia
  著者:: Rijnders, Bart J. A.
  出版事項: (2003)
• Randomized Controlled Trial of Sequential Intravenous (i.v.) and Oral Moxifloxacin Compared with Sequential i.v. and Oral Co-Amoxiclav with or without Clarithromycin in Patients with Community-Acquired Pneumonia Requiring Initial Parenteral Treatment
  著者:: Finch, R., 等
  出版事項: (2002)
• Moxifloxacin Pharmacokinetic Profile and Efficacy Evaluation in Empiric Treatment of Community-Acquired Pneumonia
  著者:: Öbrink-Hansen, Kristina, 等
  出版事項: (2015)